Part B Insider (Multispecialty) Coding Alert

Part B practices will benefit from six new lab tests now classified as “CLIA-waived,” thanks to a Jan. 10 MLN Matters article on the topic.

According to article MM8560, CMS will now consider the following tests CLIA-waved. You’ll have to append modifier QW (CLIA-waived test) to most of these codes, which include the following services, among others:

• G0434 (Drug screen, other than chromatographic…) for SCI International Inc. New Choice At Home Drug Test: Marijuana (Strip Format), the Alere iCup DX 14 (Cassette Dip Card format), the American Screening Corporation Discover Drug Test Cards, and the American Screen Corporation Discover Multi-Panel Drug Test Cups
• 82465 (Cholesterol, serum or whole blood, total) for the Infopia USA, LipidPro Professional Lipid Profile and Glucose Measuring System and the Jant Pharmacal Corp. LipidPlus Professional Lipid Profile and Glucose Measuring System.

To read the article in its entirety, visit www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNMattersArticles/downloads/MM8560.pdf.